Thomasville National Bank Has $7.44 Million Stake in Aflac Incorporated (NYSE:AFL)

Thomasville National Bank trimmed its position in Aflac Incorporated (NYSE:AFL) by 0.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 66,510 shares of the financial services provider’s stock after selling 118 shares during the quarter. Thomasville National Bank’s holdings in Aflac were worth $7,436,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Y.D. More Investments Ltd acquired a new position in shares of Aflac in the second quarter valued at $25,000. Atwood & Palmer Inc. raised its stake in Aflac by 80.0% during the first quarter. Atwood & Palmer Inc. now owns 315 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 140 shares in the last quarter. OFI Invest Asset Management acquired a new position in Aflac during the first quarter worth $29,000. Dixon Mitchell Investment Counsel Inc. acquired a new position in Aflac during the first quarter worth $34,000. Finally, Cedar Wealth Management LLC acquired a new position in Aflac during the first quarter worth $50,000. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Aflac Price Performance

Aflac stock opened at $113.26 on Monday. The business’s 50-day simple moving average is $107.90 and its 200 day simple moving average is $94.96. The stock has a market cap of $64.36 billion, a price-to-earnings ratio of 12.50, a P/E/G ratio of 2.62 and a beta of 0.95. Aflac Incorporated has a 12-month low of $75.07 and a 12-month high of $115.50. The company has a quick ratio of 0.10, a current ratio of 0.10 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFL) last posted its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.60 by $0.23. The business had revenue of $5.14 billion for the quarter, compared to analysts’ expectations of $4.10 billion. Aflac had a return on equity of 16.22% and a net margin of 28.35%. The firm’s quarterly revenue was down .7% compared to the same quarter last year. During the same quarter last year, the business earned $1.58 earnings per share. As a group, research analysts anticipate that Aflac Incorporated will post 6.76 earnings per share for the current year.

Aflac Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, September 2nd. Shareholders of record on Wednesday, August 21st were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.77%. The ex-dividend date of this dividend was Wednesday, August 21st. Aflac’s dividend payout ratio (DPR) is currently 22.08%.

Insiders Place Their Bets

In other Aflac news, Director Thomas J. Kenny sold 2,000 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $98.94, for a total transaction of $197,880.00. Following the transaction, the director now owns 18,158 shares in the company, valued at approximately $1,796,552.52. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

Several research firms have issued reports on AFL. JPMorgan Chase & Co. increased their price objective on Aflac from $85.00 to $90.00 and gave the stock a “neutral” rating in a research note on Thursday, October 3rd. Piper Sandler increased their price objective on Aflac from $114.00 to $122.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 2nd. Jefferies Financial Group dropped their price objective on Aflac from $84.00 to $83.00 and set a “hold” rating for the company in a research note on Friday, June 28th. Barclays started coverage on Aflac in a research note on Wednesday, September 4th. They set an “underweight” rating and a $96.00 price objective for the company. Finally, Citigroup increased their target price on Aflac from $84.00 to $93.00 and gave the stock a “neutral” rating in a report on Tuesday, July 23rd. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, Aflac presently has a consensus rating of “Hold” and a consensus price target of $97.53.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.